Literature DB >> 3761158

[Studies on beta-lactam antibiotics for medicinal purposes. XXII. Studies on the metabolism of pivaloyloxymethyl (6R,7R)-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-3-cephem-4-carboxylate (T-2588) (2)].

I Saikawa, Y Nakajima, M Tai, H Sakai, K Demachi, T Kajita, H Hayakawa, M Onoda, H Fukuda, H Sadaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3761158

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN： 0031-6903            Impact factor:   0.302


× No keyword cloud information.
  3 in total

1.  Phase I clinical studies of S-1108: safety and pharmacokinetics in a multiple-administration study with special emphasis on the influence on carnitine body stores.

Authors:  M Nakashima; T Uematsu; T Oguma; T Yoshida; K Mizojiri; S Matsuno; S Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

2.  Metabolism of S-1108, a new oral cephem antibiotic, and metabolic profiles of its metabolites in humans.

Authors:  K Totsuka; K Shimizu; M Konishi; S Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

3.  Determination of cefcapene acid by LC-MS and their application to a pharmacokinetic study in healthy Chinese volunteers.

Authors:  Hong-Fei Duan; Li Ding; Xiao-Bing Li; Lin-Lin Hu; Ai-Dong Wen; Ye Leng; Zhen Liu
Journal:  J Pharm Anal       Date:  2012-10-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.